secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001609550-24-000013
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q4 revenue $192.5M (+40%), first net income quarter $14.8M
--------------------------------------------------------------------------

- Q4 revenue $192.5M (+40% YoY); full year $624.8M (+53%). U.S. revenue $189.4M (+41%).
- Q4 net income $14.8M (diluted EPS $0.49) vs $3.2M ($0.10) a year ago; FY net loss improved 53% to $21.2M.
- Gross margin 85.4% in Q4 vs 83.9% a year ago; FY 2024 guidance 83%-85%.
- Reaffirms FY 2024 revenue guidance of $775M-$785M (24-26% growth).
- Added 78 new U.S. implanting centers in Q4 (total 1,180) and 13 sales territories (total 287).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000013/0001609550-24-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000013/insp-20240206.htm
  HTML page:      https://secwatch.observer/filing/0001609550-24-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer